News

Gladstone in the News April 19, 2020

Nobel Laureate Yamanaka Frets over Japan’s Lax Coronavirus Fight

Nikkei Asian Review—Gladstone Senior Investigator Shinya Yamanaka is concerned about the spread of COVID-19 in Japan. To help keep people informed, he has begun a blog to share his scientific insights about the importance of social distancing and to shed light on how scientists are working to fight the virus.

Gladstone Experts COVID-19 Yamanaka Lab

Gladstone in the News April 19, 2020

What We Know, and Don’t Know, a Month into Bay Area’s Shelter-in-Place Order

San Francisco Chronicle—Senior Investigator Warner Greene describes how quick action to close businesses and send people home helped the Bay Area “crush the curve” of COVID-19.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News April 17, 2020

The Promise and Peril of Antibody Testing for COVID-19

JAMA Network—Antibody tests could help identify who has already been infected with SARS-CoV-2, and may now be immune. Gladstone Investigator Melanie Ott explains that understanding how far immunity has spread could help determine when it will be safe to ease social distancing requirements.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Article April 15, 2020

ChemPartner and Gladstone Institutes Announce COVID-19 Research Collaboration

Leading contract research and development organization partners with world-class virology team to fight the COVID-19 pandemic

COVID-19 Infectious Disease

Gladstone in the News April 14, 2020

To Accelerate Innovation, the CDC Should Ease Limits on Which Labs Can Handle the Coronavirus

STAT News—The Centers for Disease Control and Prevention currently requires that research on SARS-CoV-2, the virus that causes COVID-19, be conducted in special biosafety level 3 labs (BSL-3). Senior Investigator Melanie Ott explains why that requirement could slow down research progress.

Gladstone Experts COVID-19 Ott Lab

Gladstone in the News April 13, 2020

Coronavirus: How Is San Francisco Testing at Nearly Double the Rate of LA?

Mercury News—San Francisco has the highest per capita COVID-19 testing rate in California. Senior Investigator Warner Greene helps explain why widespread testing is so important to getting the outbreak under control.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News April 12, 2020

Bay Area Labs Fighting Coronavirus, Sometimes Leaving Regular Work Aside

San Francisco Chronicle—The COVID-19 pandemic has disrupted many industries, including biomedical research. Senior Investigators Warner Greene and Lennart Mucke describe how some labs have shifted the focus of their work to address the current crisis, while others have been forced to put important work on pause.

Research (Publication) COVID-19 Greene Lab Mucke Lab

Gladstone in the News April 9, 2020

Chloroquine, Zinc Tested to Block COVID Infection

WebMD—Scientists urge that testing be completed on drugs, such as chloroquine or hydroxychloroquine, before being used on patients, to prevent possible negative and unintended effects.

Communications COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab

Gladstone in the News April 9, 2020

Coronavirus Treatment: San Francisco Scientists’ Stem Cell Research Could Help in COVID-19 Fight

ABC7 News—While some COVID-19 cases are severe and cause rapid decline, other patients experience only mild symptoms. Gladstone President Deepak Srivastava explains how stem cell research could help explain this phenomenon, and lead to targeted treatments.

Research (Publication) COVID-19 Stem Cells/iPSCs

Gladstone in the News April 9, 2020

You Need a Special Lab to Study the Coronavirus. Here’s What It Takes to Get One up and Running.

STAT News—Gladstone Investigator Melanie Ott describes what’s necessary to set up a biosafety level 3 lab (BSL-3) for research on live coronavirus.

Gladstone Experts Research (Publication) COVID-19 Ott Lab

Gladstone in the News April 8, 2020

Inside the Unprecedented Global Race for a Coronavirus Cure

Nikkei Asian Review—Gladstone Senior Investigator Nevan Krogan describes how his lab launched a collaborative effort to map all human proteins that interact with SARS-CoV-2, the virus that causes COVID-19. Through this heroic effort, a map was produced in just a few weeks. Now, the team is testing to see if drugs can be used to disrupt those interactions to fight the infection.

Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab

Gladstone in the News April 8, 2020

The Best Hopes for a Coronavirus Drug

The Atlantic—The coronavirus has only 29 proteins. How is it possible that so few amounts can wreak havoc with the tens of thousands of healthy proteins in our bodies?

Communications COVID-19 Infectious Disease Ott Lab

Gladstone in the News April 7, 2020

Tackling Heart Disease

The Stem Cell Podcast—Gladstone President Deepak Srivastava describes his work using human induced pluripotent stem cells to investigate the gene networks that dictate cell fate decisions, and how this research could lead to therapeutics for congenital heart disease and heart failure. He also describes the importance of stem cell research in fighting the COVID-19 pandemic.

Gladstone Experts COVID-19 Heart Failure Congenital Heart Disease Cardiovascular Disease Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs

Gladstone in the News April 7, 2020

Searching for a Coronavirus Cure in the Blood

Chemical and Engineering News (C&EN)—Will convalescent plasma, the antibody-rich portion of blood donated from someone who recovered from the disease, be the answer to helping patients that are sick with the coronavirus? History may repeat itself, as this was one solution used to combat the Spanish flu of 1918.

Communications COVID-19 Infectious Disease Greene Lab

Gladstone in the News April 6, 2020

Scientists around the Globe Pivot Their Research to SARS-CoV-2

The Scientist—Gladstone researchers quickly pivot to work to get SARS-CoV-2 research up and running. The Ott Lab is relying on previously established lung organoids to test the effects of the virus.

Communications COVID-19 Infectious Disease Ott Lab